Cargando…
Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms()
By using a large international firm-level data set this paper aims to make a contribution in better understanding how COVID-19 related stringency and economic support measures actually affected the corporate sector. Our most important findings can be summarized as follows: First, we find robust evid...
Autores principales: | Haimann, Michael, Kaserer, Christoph, Ljubicic, Kristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Board of Trustees of the University of Illinois. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122544/ https://www.ncbi.nlm.nih.gov/pubmed/37132001 http://dx.doi.org/10.1016/j.qref.2023.04.002 |
Ejemplares similares
-
Cui Bono?
Publicado: (1869) -
Metformin and cancer: Quo vadis et cui bono?
por: Menendez, Javier A., et al.
Publicado: (2016) -
The impact of economic policy uncertainty on firms’ investment in innovation: Evidence from Chinese listed firms
por: Kun, Wen, et al.
Publicado: (2022) -
COVID-19 impact on firm investment—Evidence from Chinese publicly listed firms
por: Jiang, Jie, et al.
Publicado: (2021) -
The Impact of Environmental Information Disclosure on the Firm Value of Listed Manufacturing Firms: Evidence from China
por: Yang, Yongliang, et al.
Publicado: (2020)